Back to Jobs
Ultragenyx
Marketing & Sales 9h ago

UltraCare Liaison (UCL)

Ultragenyx
FloridaFlorida
Full-time
$153,100 — $189,100 USD
Senior-Level

Job Description

Key Skills Required

Master these to land this role

Sales RepresentativeHealthcare SalesLead Generation

Want to know if you're a match for this job?

Calculate My Match Score

Position Summary:

We are looking for experienced UltraCare Liaisons (UCLs) that will represent Ultragenyx in the Rare Disease Community, responsible for the promotion of Dojolvi for the treatment of long chain fatty oxidation disorders (LC-FAOD). Ultragenyx is also preparing for the potential commercialization of two investigational novel gene therapies in MPSIIIA and GSD1a. We are seeking driven individuals with the desire to run their own business within a specified geography. These individuals will have strong business acumen, be able to drive change through innovative approaches, demonstrate excellent communication skills and consistently deliver sales results.

Work Model:

Field: Officially documented as working as a member of the Ultragenyx field team, generally interacting with third parties on behalf of Ultragenyx.

Responsibilities:

  • Serve as territory business owner with a focus upon impact and territory analysis. Other key areas of focus include optimizing: i) patient diagnosis and care through HCP education, ii) educating HCPs about Ultragenyx approved products, iii) assisting with treatment fulfillment
  • Ability to develop and nurture effective business relationship management with key stakeholders, including HCPs, Registered Dieticians, Genetic Counselors, Pharmacists, and related support staff
  • Proactively builds effective working relationships with internal/external stakeholders; can drive agreement/decisions from multiple stakeholders; ability to understand people’s emotions and flex communication style. Can adjust their approach based on different stakeholder needs, concerns, or audience member to drive alignment and meet their work goals.
  • Develop and maintain a strategic territory business plan focused on key academic centers, community targets within priority specialties, territory opportunities and challenges.
  • Determines and implements suitable travel schedule and call plan on a daily/weekly basis to ensure both adequate and highly effective coverage for all key accounts.
  • Executes programs, high impact in-services, and other educational opportunities for their territory.
  • Timely completion of compliance trainings, internal product & disease state trainings, Veeva administration, monthly expense reports, and all other administration expectations.

Requirements:

  • Bachelor’s Degree required
  • 8 years with 5+ years being in the healthcare/biotech industry, inclusive of 3 years of field-based experience in account management, sales, and/or field reimbursement. Rare disease experience is preferred.
  • Experience launching biopharma/pharma products successfully is preferred
  • Documented track record of field sales success
  • Strategic business acumen and cross-functional and collaborative leadership with internal stakeholders including marketing, medical, clinical operations, and patient services.
  • Demonstrated experience effectively presenting clinical/scientific information required
  • Approximately 50 - 60% (dependent on geography) travel is required; overnight travel is required as needed
  • Must live in territory geography. Territory includes: Florida and Georgia. The desired location to live is Florida. Territory subject to change based on business need.

How would you rate this job post?

See what other professionals think about this role.

banner

Ultragenyx (operating at ultragenyx.com) is a biopharmaceutical company engineered for developing therapies for people living with rare and ultra-rare genetic diseases. Founded in 2010 by Emil Kakkis and headquartered in Novato, California, Ultragenyx focuses on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward. Under the hood, the company identifies, acquires, develops, and commercializes novel products for treatment of rare and ultrarare diseases. This allows patients and families affected by these diseases to access innovative treatments and improve their quality of life. Backed by significant funding, including a valuation of $271 million in 2020.

Safety First

  • Never pay for a job application.
  • Do not share sensitive bank info.
  • Verify the client before starting work.
Learn More